Seth Wander, MD, PhD
Director of Translational Research, Massachusetts General Hospital; Director of Precision Medicine, Termeer Center for Targeted Therapies; Assistant Professor, Harvard Medical School
Highlights
- Speaker, 2026 Conference on Metastatic Breast Cancer
- Speaker, Biomarker testing for early-stage breast cancer
- Medical oncologist and translational researcher specializing in breast cancer genomics and precision medicine
- Dana-Farber Cancer Institute Wong Family Translational Research Award recipient
- Conquer Cancer Foundation/American Society of Clinical Oncology Young Investigator Award recipient
Seth Wander, MD, PhD, is a medical oncologist at the Massachusetts General Hospital with clinical and translational research expertise in breast cancer and cancer genomics. He serves as the director of translational research for the Breast Oncology Program, where he leads a multidisciplinary team focused on understanding how cancers develop resistance to standard therapies and on advancing novel, personalized treatment approaches.
Dr. Wander also serves as director of precision medicine in the Termeer Center for Targeted Therapies, where he leads efforts across the Massachusetts General Hospital Cancer Center to integrate emerging genetic and molecular sequencing technologies into cancer research and clinical trial design. His work has helped shape current understanding of drug resistance in metastatic breast cancer and supports the development of new therapeutic strategies across all phases of drug development.
He earned his undergraduate degree in molecular and cell biology at Cornell University, where he graduated magna cum laude with distinction in research, and completed his MD and PhD in cancer biology at the University of Miami. Dr. Wander completed his internship and internal medicine residency at the Massachusetts General Hospital and his fellowship training in medical oncology at the Dana-Farber Cancer Institute and the Massachusetts General Hospital Cancer Center. He is an assistant professor of medicine at Harvard Medical School and remains engaged in the education and mentorship of medical students, residents, and fellows.
Dr. Wander’s work has been recognized with multiple honors, including the Dana-Farber Cancer Institute Wong Family Translational Research Award (2017) and the Conquer Cancer Foundation/American Society of Clinical Oncology Young Investigator Award (2018).